Effects of duloxetine on painful physical symptoms associated with depression

被引:125
作者
Goldstein, DJ
Lu, YL
Detke, MJ
Hudson, J
Iyengar, S
Demitrack, MA
机构
[1] PRN Consulting, Indianapolis, IN 46260 USA
[2] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46204 USA
[3] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46204 USA
[4] Lilly Res Labs, Joint Antidepressant Team Cymbalta, Indianapolis, IN USA
[5] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA
[6] McLean Hosp, Psychiat Epidemiol Lab, Belmont, MA 02178 USA
[7] Wyeth Pharmaceut, Dept Neurosci, Radnor, PA USA
关键词
D O I
10.1176/appi.psy.45.1.17
中图分类号
R749 [精神病学];
学科分类号
100205 [精神病与精神卫生学];
摘要
Painful physical symptoms are common features of major depressive disorder and may be the presenting complaints in primary care settings. The effect of the dual serotonin (5-HT) and norepinephrine reuptake inhibitor duloxetine on emotional and painful physical symptoms in outpatients with major depressive disorder was evaluated in three randomized, double-blind, placebo-controlled trials. The trials' primary objective was to evaluate the effect of duloxetine on mood, and subjects were not enrolled on the basis of presence, type, or severity of pain. However, the pain-relieving effects of duloxetine were evaluated by a priori defined analyses of results from a visual analogue scale and the Somatic Symptom Inventory. Compared with placebo, duloxetine was associated with significant reduction in pain severity The authors concluded that duloxetine reduces the painful physical symptoms of depression.
引用
收藏
页码:17 / 28
页数:12
相关论文
共 49 条
[1]
A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia [J].
Arnold, LM ;
Hess, EV ;
Hudson, JI ;
Welge, JA ;
Berno, SE ;
Keck, PE .
AMERICAN JOURNAL OF MEDICINE, 2002, 112 (03) :191-197
[2]
BARSKY AJ, 1986, ARCH GEN PSYCHIAT, V43, P493
[3]
Headache and major depression - Is the association specific to migraine? [J].
Breslau, N ;
Schultz, LR ;
Stewart, WF ;
Lipton, RB ;
Lucia, VC ;
Welch, KMA .
NEUROLOGY, 2000, 54 (02) :308-313
[4]
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors [J].
Bymaster, FP ;
Dreshfield-Ahmad, LJ ;
Threlkeld, PG ;
Shaw, JL ;
Thompson, L ;
Nelson, DL ;
Hemrick-Luecke, SK ;
Wong, DT .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (06) :871-880
[5]
Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review [J].
Collins, SL ;
Moore, RA ;
McQuay, HJ ;
Wiffen, P .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 20 (06) :449-458
[6]
CROFT P, 1993, J RHEUMATOL, V20, P710
[7]
Delgado PL, 2000, J CLIN PSYCHIAT, V61, P5
[8]
The visual analog scale in the immediate postoperative period: Intrasubject variability and correlation with a numeric scale [J].
DeLoach, LJ ;
Higgins, MS ;
Caplan, AB ;
Stiff, JL .
ANESTHESIA AND ANALGESIA, 1998, 86 (01) :102-106
[9]
Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression [J].
Detke, MJ ;
Lu, YL ;
Goldstein, DJ ;
McNamara, RK ;
Demitrack, MA .
JOURNAL OF PSYCHIATRIC RESEARCH, 2002, 36 (06) :383-390
[10]
Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial [J].
Detke, MJ ;
Lu, YL ;
Goldstein, DJ ;
Hayes, JR ;
Demitrack, MA .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (04) :308-315